LONDON — As we move through 2021, there are more signs of a return to pre-pandemic normalcy, at least in countries not reeling from dangerous new variants of the coronavirus.

LONDON — I was recently approached about setting up my own “special purpose acquisition company” (SPAC), which would allow me to secure financial commitments from investors on the expectation that I will eventually acquire some promising business that would prefer to avoid an ini

LONDON  —  It is probably premature to offer an assessment of the COVID-19 pandemic’s possible consequences, not least because there may well be many more twists and turns to come.

LONDON — This November will mark the 20th anniversary of the BRIC acronym that I coined to capture the economic potential of Brazil, Russia, India and China.

LONDON — In two of my previous commentaries on the peculiar world of equity markets in 2020, I offered a bullish outlook for how events would unfold as the year progressed, with all due caveats for the market’s overall unpredictability.

LONDON — We may soon witness the bargain of the century.

LONDON — Large swaths of the global economy are exhibiting traditional signs of a V-shaped recovery from the pandemic-induced collapse this spring.

LONDON — In an April commentary about the wild gyrations in financial markets during the February-March phase of the COVID-19 pandemic, I noted that the behaviour of equity markets had been as bewildering, complex and fascinating as ever.

LONDON — Earlier this month, the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) launched a nearly $1 billion AMR (antimicrobial resistance) Action Fund to support the development of desperately needed new antibiotics.